Benjamin L. Ebert
Broad Institute
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Protein Degradation and Inhibitors
Strong evidence · 3 supporting papers · latest 2026
Multiple Myeloma Research and Treatments
Strong evidence · 2 supporting papers · latest 2026
Acute Myeloid Leukemia Research
Strong evidence · 6 supporting papers · latest 2026
Sarcoma Diagnosis and Treatment
Strong evidence · 1 supporting paper · latest 2025
Vascular Tumors and Angiosarcomas
Strong evidence · 1 supporting paper · latest 2025
Nanofabrication and Lithography Techniques
Solid evidence · 1 supporting paper · latest 2026
Analytical Chemistry and Sensors
Solid evidence · 1 supporting paper · latest 2026
Photonic and Optical Devices
Solid evidence · 1 supporting paper · latest 2026
Publications (13)
Somatic mutations in STAG2 are associated with separated megakaryocyte nuclear lobes in myelodysplastic syndromes
2025DOIPMID 40720765
Charged molecular glue discovery enabled by targeted degron display
2026DOIPMID 41942733
Development of FBXO22 Degraders and the Recruitment Ligand 2-Pyridinecarboxyaldehyde (2-PCA)
2025DOIPMID 41292500
Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response
2026DOIPMID 42336819
DCAF11-dependent molecular glue degrader activated by glutathionylation
2026DOIPMID 42557329
MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma
2026DOIPMID 42498680
Human plasma proteomic profile of clonal hematopoiesis
2025DOIPMID 41309676
In silico design of degron tags for precise modulation of CAR T-cell activity using clinically utilized drugs
2025DOI
Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesis
2026DOIPMID 41672066
Endogenous aldehydes: A driver of clonal hematopoiesis from within?
2026DOIPMID 41932322
Transgenic expression of enhanced AsCas12a in mice enables In Vivo multiplex genetic editing and development of diverse novel models of myeloid neoplasms
2025DOI
Data-driven modelling of the fume emission rate for gas metal arc welding
2026DOI
Clonal hematopoiesis and lung adenocarcinoma pathogenesis
2025DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Broad Institute
- Dana-Farber Cancer Institute
Source: OpenAlex · retrieved 2026-09-29